BioNxt Solutions Inc.
WKN: A3D1K3 | ISIN: CA0909741062 | CSE: BNXT | FSE: 4XT | OTCQB: XPHYF

BioNxt Solutions is an emerging innovator in the drug delivery and rapid diagnostics industry. The Company’s work is focused on in-house and contract drug formulation programs based on its transdermal and oral dissolvable drug delivery platforms. BioNxt has also leveraged it’s drug delivery technology into the rapid diagnostics sector with several oral dissolvable biosensor products under development for oral health and infectious disease. The company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.